Position history for GOLDMAN SACHS GROUP INC's holdings in ATRIUM THERAPEUTICS INC
GOLDMAN SACHS GROUP INC holds 349,950 shares of RNA (ATRIUM THERAPEUTICS INC), worth $4.7M as of 2026-Q1. This is a new position. RNA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.
Current Value
$4.7M
Current Shares
349,950
Total Value Change
$0
Total Shares Change
0
Other major holders of RNA: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Pentwater Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC
New |
| 349,950 |
- |
| $4.7M |
| 0.0% |
| $15.67 |
37 |